Chen ZY - Search Results

1

Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.

Zhang Y, Wang MY, He J, Wang JC, Yang YJ, Jin L, Chen ZY, Ma XJ, Sun MH, Xia KQ, Hong XN, Wei QY, Zhou XY. Zhang Y, et al. Among authors: chen zy. PLoS One. 2012;7(5):e37846. doi: 10.1371/journal.pone.0037846. Epub 2012 May 29. PLoS One. 2012. PMID: 22666399 Free PMC article.

2

[Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].

Chen ZY, Zhou XY, Zhang TM, Hong XN, Yin JL, Hu XC, Shi DR. Chen ZY, et al. Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):183-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615255 Chinese.

3

GSTM1 null allele is a risk factor for gastric cancer development in Asians.

Qiu LX, Wang K, Lv FF, Chen ZY, Liu X, Zheng CL, Li WH, Zhu XD, Guo WJ, Li J. Qiu LX, et al. Among authors: chen zy. Cytokine. 2011 Jul;55(1):122-5. doi: 10.1016/j.cyto.2011.03.004. Epub 2011 Apr 6. Cytokine. 2011. PMID: 21474334

4

Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.

Geng R, Chen Z, Zhao X, Qiu L, Liu X, Liu R, Guo W, He G, Li J, Zhu X. Geng R, et al. PLoS One. 2014 Dec 29;9(12):e116027. doi: 10.1371/journal.pone.0116027. eCollection 2014. PLoS One. 2014. PMID: 25545243 Free PMC article.

5

miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.

Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J. Li W, et al. Oncotarget. 2015 Sep 15;6(27):24448-62. doi: 10.18632/oncotarget.4423. Oncotarget. 2015. PMID: 26259252 Free PMC article.

6

Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.

Liu R, Zhao X, Liu X, Chen Z, Qiu L, Geng R, Guo W, He G, Yin J, Li J, Zhu X. Liu R, et al. Tumour Biol. 2016 Feb;37(2):1753-62. doi: 10.1007/s13277-015-3935-8. Epub 2015 Aug 28. Tumour Biol. 2016. PMID: 26314858

7

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.

Liu X, Guo W, Zhang W, Yin J, Zhang J, Zhu X, Liu T, Chen Z, Wang B, Chang J, Lv F, Hong X, Wang H, Wang J, Zhao X, Wu X, Li J. Liu X, et al. BMC Cancer. 2017 Mar 14;17(1):188. doi: 10.1186/s12885-017-3174-z. BMC Cancer. 2017. PMID: 28288572 Free PMC article. Clinical Trial.

8

Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients.

Liu J, Chen Z, Chen H, Hou Y, Lu W, He J, Tong H, Zhou Y, Cai W. Liu J, et al. Int J Mol Sci. 2017 Mar 13;18(3):603. doi: 10.3390/ijms18030603. Int J Mol Sci. 2017. PMID: 28335376 Free PMC article.

9

LRP5 polymorphism-A potential predictor of the clinical outcome in advanced gastric cancer patients treated with EOF regimen.

Liu X, Huang MZ, Chen ZY, Zhao XY, Wang CC, Peng W, Yin JL, Li J, Zhu XD. Liu X, et al. Among authors: chen zy. Chin J Cancer Res. 2014 Aug;26(4):478-85. doi: 10.3978/j.issn.1000-9604.2014.08.22. Chin J Cancer Res. 2014. PMID: 25232223 Free PMC article.

10

Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen.

Liu X, Chen Z, Zhao X, Huang M, Wang C, Peng W, Yin J, Li J, He G, Li X, Zhu X. Liu X, et al. Pharmacogenomics. 2015;16(9):959-70. doi: 10.2217/pgs.15.49. Epub 2015 Jun 26. Pharmacogenomics. 2015. PMID: 26115082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,090 results

Search Page

Filters